Comparing the Apelin Level in Hypertensive Patients Who Received Hypertension Drugs
Open Access
- 3 February 2021
- journal article
- research article
- Published by Brieflands in Modern Care Journal
- Vol. 17 (4)
Abstract
Background: Apelin, an adipokine secreted from adipose tissue, plays an important role in regulating blood pressure and hypertension. Objectives: The current study aimed to compare the plasma Apelin level in hypertensive patients under treatment with amlodipine, losartan, and amlodipine + losartan. Methods: In this case-control study, the serum level of Apelin was compared in four groups of (A) Healthy subjects (n = 31); (B) Hypertensive patients, received amlodipine (n = 31); Hypertensive patients, received losartan (n = 45); and patients (n = 33) that received amlodipine and losartan. Apelin level in serum samples was measured using Human Apelin ELISA Kit according to the manufacturers’ instructions. Data were analyzed using SPSS version 19 (Chicago: SPSS Inc.), at the significant level of α = 0.05. Results: The mean blood level of Apelin in the control group and groups receiving amlodipine, losartan, and amlodipine + losartan was 366.16 ± 36.04, 247.19 ± 27.77, 282.93 ± 47.08, and 289.84 ± 32.20 g/dl, respectively. Losartan + amlodipine group had a higher level of Apelin compared with amlodipine alone (P < 0.05). Conclusions: This study demonstrated that Apelin has a definite protective effect in preventing hypertension. Also, according to the results, the renin-angiotensin-aldosterone system inhibitors, such as losartan, caused a higher increase in the Apelin, resulting in better blood pressure control.Keywords
This publication has 23 references indexed in Scilit:
- Blood pressure and heart failureClinical Hypertension, 2020
- Prevalence of Systemic Arterial Hypertension Diagnosed, Undiagnosed, and Uncontrolled in Elderly Population: SABE StudyJournal of Aging Research, 2019
- The Role of Apelin in Cardiovascular Diseases, Obesity and CancerFrontiers in Physiology, 2018
- The apelin-APJ system in the evolution of heart failureMedicine and Pharmacy Reports, 2015
- Apelin and its receptor APJ in cardiovascular diseasesClinica Chimica Acta, 2014
- Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryoDevelopmental Biology, 2006
- Emerging roles of apelin in biology and medicinePharmacology & Therapeutics, 2005
- Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac ContractilityCirculation Research, 2002
- The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanismRegulatory Peptides, 2001
- [125I]‐(Pyr1)Apelin‐13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in manBritish Journal of Pharmacology, 2001